Glaxosmithkline Pharmaceuticals has reported results for second quarter ended September 30, 2017.
The company has reported a rise of 31.84% in its net profit at Rs 130.32 crore for the quarter under review as compared to net profit of Rs 98.85 crore for the same quarter in the previous year. Total income of the company increased by 3.51% at Rs 845.87 crore for Q2FY18 as compared Rs 817.20 crore for the corresponding quarter previous year.
GlaxoSmithKline Pharmaceuticals is a subsidiary of GlaxoSmithKline plc, one of the world's leading research-based pharmaceutical and healthcare companies, committed to improving the quality of human life by enabling people to do more, feel better and live longer.
